M. Vivarelli, L. Massella, B. Ruggiero, and F. Emma, Minimal Change Disease, Clin. J. Am. Soc. Nephrol, vol.12, pp.332-345, 2017.

R. J. Maas, J. K. Deegens, and J. F. Wetzels, Permeability factors in idiopathic nephrotic syndrome: Historical perspectives and lessons for the future, Nephrol. Dial. Transplant, vol.29, pp.2207-2216, 2014.

D. Sahali, K. Sendeyo, M. Mangier, V. Audard, S. Y. Zhang et al., Immunopathogenesis of idiopathic nephrotic syndrome with relapse, Semin. Immunopathol, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01059437

R. J. Maas, J. K. Deegens, B. Smeets, M. J. Moeller, and J. F. Wetzels, Minimal change disease and idiopathic FSGS: Manifestations of the same disease, Nat. Rev. Nephrol, vol.12, pp.768-776, 2016.

P. W. Mathieson, Immune dysregulation in minimal change nephropathy, Nephrol. Dial. Transplant, vol.18, pp.26-29, 2003.

A. Jamin, L. Berthelot, A. Couderc, J. M. Chemouny, E. Boedec et al., Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice, J. Autoimmun, vol.89, pp.149-161, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02445649

R. M. Lombel, D. S. Gipson, and E. M. Hodson, Kidney Disease: Improving Global Outcomes Treatment of steroid-sensitive nephrotic syndrome: New guidelines from KDIGO, Pediatr. Nephrol, vol.28, pp.415-426, 2013.

A. Pasini, E. Benetti, G. Conti, L. Ghio, M. Lepore et al., The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I-Diagnosis and treatment of the first episode and the first relapse, Ital. J. Pediatr, vol.43, p.41, 2017.

S. Samuel, M. Bitzan, M. Zappitelli, A. Dart, C. Mammen et al., Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children, Am. J. Kidney Dis, vol.63, pp.354-362, 2014.

N. Pravitsitthikul, N. S. Willis, E. M. Hodson, and J. C. Craig, Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children, Cochrane database Syst. Rev, 2013.

D. C. Cattran, E. Alexopoulos, P. Heering, P. F. Hoyer, A. Johnston et al., Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations, Kidney Int, vol.72, pp.1429-1447, 2007.

M. P. Gruppen, A. H. Bouts, M. C. Jansen-van-der-weide, M. P. Merkus, A. Zurowska et al., A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome, Kidney Int, vol.93, pp.510-518, 2018.

T. Takei, M. Itabashi, T. Moriyama, C. Kojima, S. Shiohira et al., Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults, Nephrol. Dial. Transplant, vol.28, pp.1225-1232, 2013.

J. Guitard, A. Hebral, F. Fakhouri, D. Joly, E. Daugas et al., Rituximab for minimal-change nephrotic syndrome in adulthood: Predictive factors for response, long-term outcomes and tolerance, Nephrol. Dial. Transplant, vol.29, pp.2084-2091, 2014.

R. D. Gilbert, E. Hulse, and S. Rigden, Rituximab therapy for steroid-dependent minimal change nephrotic syndrome, Pediatr. Nephrol, vol.21, pp.1698-1700, 2006.

H. Munyentwali, K. Bouachi, V. Audard, P. Remy, P. Lang et al., Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease, Kidney Int, vol.83, pp.511-516, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919110

A. H. Kim, J. Chung, S. Akilesh, A. Koziell, S. Jain et al., B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement, JCI Insight, vol.2, 2017.

P. Rémy, V. Audard, P. A. Natella, G. Pelle, B. Dussol et al., An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study), Kidney Int, vol.94, pp.1217-1226, 2018.

X. Li, Z. Liu, L. Wang, R. Wang, G. Ding et al., Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome, J. Am. Soc. Nephrol, vol.28, pp.1286-1295, 2017.

A. Khwaja and . Kdigo, Clinical Practice Guideline for Acute Kidney Injury, Nephron Clin. Pract, vol.120, pp.179-184, 2012.

M. Waldman, R. J. Crew, A. Valeri, J. Busch, B. Stokes et al., Adult minimal-change disease: Clinical characteristics, treatment and outcomes, Clin. J. Am. Soc. Nephrol, vol.2, pp.445-453, 2007.

K. Tse, M. Lam, P. Yip, F. Li, B. Choy et al., Idiopathic minimal change nephrotic syndrome in older adults: Steroid responsiveness and pattern of relapses, Nephrol. Dial. Transplant, vol.18, pp.1316-1320, 2003.

M. Nakayama, R. Katafuchi, T. Yanase, K. Ikeda, H. Tanaka et al., Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome, Am. J. Kidney Dis, vol.39, pp.503-512, 2002.

J. Huang, S. Hsu, F. Chen, J. Sung, C. Tseng et al., Adult-Onset Minimal Change Disease among Taiwanese, Am. J. Nephrol, vol.21, pp.28-34, 2001.

R. J. Maas, J. K. Deegens, J. R. Beukhof, L. J. Reichert, M. A. Ten-dam et al., The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series, Am. J. Kidney Dis, vol.69, pp.637-646, 2017.

A. Meyrier and P. Niaudet, Acute kidney injury complicating nephrotic syndrome of minimal change disease, Kidney Int, vol.94, pp.861-869, 2018.

S. Li, Y. Tu, C. Zhou, L. Zhang, and Z. Liu, Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome, Clin. Exp. Nephrol, vol.20, pp.212-217, 2016.

C. Wang, R. S. Liverman, R. Garro, R. P. George, A. Glumova et al., Ofatumumab for the treatment of childhood nephrotic syndrome, Pediatr. Nephrol, vol.32, pp.835-841, 2017.

B. Basu, Ofatumumab for rituximab-resistant nephrotic syndrome, N. Engl. J. Med, vol.370, pp.1268-1270, 2014.

A. Gulati, A. Sinha, S. C. Jordan, P. Hari, A. K. Dinda et al., Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: Multicentric report, Clin. J. Am. Soc. Nephrol, vol.5, pp.2207-2212, 2010.

A. Magnasco, P. Ravani, A. Edefonti, L. Murer, L. Ghio et al., Rituximab in children with resistant idiopathic nephrotic syndrome, J. Am. Soc. Nephrol, vol.23, pp.1117-1124, 2012.

K. Dahan, H. Debiec, E. Plaisier, M. Cachanado, A. Rousseau et al., Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up, J. Am. Soc. Nephrol, vol.28, pp.348-358, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01490466